Barclays Trims CVS Health (NYSE:CVS) Target Price to $75.00

CVS Health (NYSE:CVS - Get Free Report) had its target price reduced by equities research analysts at Barclays from $82.00 to $75.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has an "overweight" rating on the pharmacy operator's stock. Barclays's price target suggests a potential upside of 31.93% from the company's current price.

Several other analysts have also recently weighed in on the stock. Wells Fargo & Company increased their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an "equal weight" rating in a research note on Monday, August 12th. Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. TD Cowen upgraded shares of CVS Health from a "hold" rating to a "buy" rating and boosted their price target for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $74.89.

CVS Health Price Performance

Shares of NYSE CVS opened at $56.85 on Wednesday. The firm has a market cap of $71.37 billion, a PE ratio of 9.99, a PEG ratio of 0.93 and a beta of 0.54. The firm has a fifty day moving average of $59.87 and a 200 day moving average of $60.19. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health has a one year low of $52.77 and a one year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to analysts' expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 earnings per share. As a group, research analysts predict that CVS Health will post 6.51 EPS for the current fiscal year.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter worth approximately $31,000. First Community Trust NA grew its holdings in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the third quarter valued at $33,000. ORG Partners LLC raised its stake in shares of CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator's stock worth $35,000 after buying an additional 592 shares during the last quarter. Finally, Oliver Lagore Vanvalin Investment Group boosted its position in shares of CVS Health by 71.0% in the 2nd quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator's stock worth $35,000 after buying an additional 247 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.